{
    "nct_id": "NCT04449510",
    "official_title": "Short-Term Cardiovascular Effects of E-Cigarettes: Influence of E-Liquid pH",
    "inclusion_criteria": "* Heart rate < 105 beats per minute (BPM)*\n* Systolic Blood pressure <160 and > 90*\n* Diastolic Blood Pressure <100 and > 50*\n* Body Mass Index (BMI) < 38.0 (at investigator's discretion for higher BMI if no other concurrent health issues)\n\n  *considered out of range if both machine and manual readings are above/below these thresholds\n* Use e-cigarettes on at least 15 days in the past 30 for at least 3 months\n* Smoke 10 or fewer cigarettes/tobacco products per day in the last 30 days\n* Willing to use mod e-cigarette\n* Willing to abstain from tobacco product use for night before study\n* Age: > 21 years old and < 70 years old\n* Using e-liquid > 0mg/ml nicotine\n* Saliva cotinine of â‰¥ 30 ng/ml or NicAlert=6 (in cases where lab turn around time will delay study procedure)\nHealthy volunteers allowed\nMust have minimum age of 21 Years\nMust have maximum age of 70 Years",
    "exclusion_criteria": "* Seizures\n* Cancer\n* Hepatitis B or C or Liver Disease\n* Oral Thrush\n* Heart disease\n* Glaucoma\n* Kidney disease or urinary retention\n* Diabetes\n* High Blood Pressure (taking sympatholytic medications such as alpha and beta blockers)\n* History of stroke\n* An ulcer in the past year\n* Thyroid disease (okay if controlled with medication)\n* Active use of an inhaler for asthma or Chronic Obstructive Pulmonary Disease (COPD)\n* Psychiatric conditions\n* Current or past schizophrenia, and/or current or past bipolar disorder\n* Major depression, current or within the past year\n* Major personality disorder\n* Participants with current or past minor or moderate depression and/or anxiety disorders will be reviewed by the study physician and considered for inclusion.\n* History of psychiatric hospitalizations are not exclusionary, but study participation will be determined as per study physician's approval\n* Recent onset or change in cough, fever and/or abdominal symptoms (vomiting or pain) in the past two weeks. (If yes, participant can re-screen when symptoms resolve).\n* Drug/Alcohol Dependence\n* Alcohol or illicit drug dependence within the past 12 months with the exception of those who have recently completed an alcohol/drug treatment program\n* Positive toxicology test at the screening visit (THC & prescribed medications okay)\n* Opioid replacement therapy (including methadone, buprenorphine, or other)\n* Positive urine cannabis is not exclusionary but participant must report use of cannabis and agree to abstain from cannabis use for the duration of the study\n* Psychiatric medications\n* Current regular use of any psychiatric medications with the exception of Selective Serotonin Reuptake Inhibitor (SSRI) and serotonin-norepinephrine reuptake Inhibitor (SNRIs) and current evaluation by the study physician that the participant is otherwise healthy, stable, and able to participate.\n* Medications\n* Use of medications that are inducers of nicotine metabolizing enzyme CYP2A4 (Example: rifampicin, carbamazepine, phenobarbital, and other anticonvulsant drugs).\n* Concurrent use of nicotine-containing medications\n* Any stimulant medications (example: Adderall) generally given for Attention deficit hyperactivity disorder (ADHD) treatment\n* Use of sympatholytic medications that affect cardiovascular conditions including hypertension, (Example: beta and alpha-blockers)\n* Other/Misc. Chronic Health Conditions\n* Fainting (within the last 30 days)\n* Other \"life threatening illnesses\" as per study physician's discretion\n* Pregnancy\n* Pregnancy (self-reported and urine pregnancy test)\n* Breastfeeding (determined by self-report)\n* Concurrent participation in another clinical trial\n* Inability to communicate in English\n* Planning to quit vaping within the next 60 days\n* Uncomfortable with getting blood drawn",
    "miscellaneous_criteria": ""
}